The company will use the funds to scale operations and accelerate its innovation and commercialization initiatives.
The company will use the funds to expand access to its hormonal healthcare platform across the U.S.
The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.
DeepScribe will be the first ambient AI partner for Flatiron Health, and will integrate with Flatiron's OncoEMR.
The partnership gives Lantern clients entry into customized substance use disorder treatment and telemedicine services.
Ashkan Afkhami of BCG X sat down with MobiHealthNews during JPM to discuss the U.S. health system's strengths, challenges in cost control and the transformative potential of AI.
The olivia app will allow patients to aggregate their health data in a central location.
The aim of the partnership is to allow healthcare providers to offer precision medicine support tools.
The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.
SpaceX's Dragon spacecraft, which recently returned from the ISS, included 50 biotechnology, physical science and student research payloads.
